Team says the treatment threshold is too high for those over 60 years of age.
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death.
Changes in individual lifestyles and how foods are produced are needed to lower consumption.
Research challenges previous findings that suggest ACE inhibitors have greater benefits.
Decrease in age-adjusted death rates from 2000 to 2012; increase from 2012 to 2014.
Online communications reduced need for phone calls and office visits for many.
Renal denervation appears relatively safe and effective, according to recent research.
Sodium restriction linked to increased risk of death or heart failure hospitalization.
Reductions in risks of major CVD events, coronary heart disease, stroke, and heart failure.
Drug found to limit worsening of the disease and reduce the need for hospitalization.
Nitrates reduce activity, quality of life, researchers find.
Analysis of data from the HALT PKD trial showed that 0% to 0.4% of patients experienced potassium levels above 6.5 mEq/L.
Hospitalization reported as imminent for 52.8% of patients but observed rate is 31.7%.
The medication significantly decreased potassium levels over 52 weeks in patients with resistant hypertension and diabetic kidney disease.
Researchers find both common treatments produce modest BP decreases in sleep apnea patients.
In a study, ramipril was not significantly better than placebo in preserving renal function in kidney transplant recipients.
The medications are associated with reduced odds of kidney failure and death compared with angiotensin II receptor blockers.
Estimated yearly incidence rate up by 5.2% per year from 2006 to 2012 for HTN-linked ER visits.
Drugs administered in patients with uncontrolled BP for levels not linked to immediate CV risk.
Findings for computed tomography scanning followed by adrenal venous sampling.
Both associated with increased aortic stiffness, renal injury, incident cardiovascular events
The CDC reports improvement since 1999, but rates of blood pressure control still fall short of the Healthy People 2020 goal.
Risk of CVD was lowered by 25%, while all-cause mortality risk was reduced 27%.
Multiple demographic and health characteristics can estimate projected long-term risk.
Physicians may need to ask young adults about energy drink intake in emergency settings.
Untreated hypertension linked to morbidity, mortality; potential harms associated with treatment.
Based on these groupings, physicians can provide more individualized treatment.
Physicians may be concerned about malpractice claims or performance measure variables.
Gout is associated with an elevated risk of comorbid conditions, especially hypertension and alcohol abuse.
On-treatment neutropenia and hypertension are independently associated with decreased mortality risk.
- Twice-Weekly Dialysis May Preserve Residual Kidney Function
- Robotic Nephrectomy of Kidney Tumors With Thrombi Feasible
- How to Prevent Sexual Transmission of Zika Virus
- Parathyroidectomy Cuts Mortality Risk in Patients With Severe SHPT
- Prostate Cancer Diagnosis Ups Risk of Non-Cancer Hospitalizations
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)